TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a leader in disinfection and decontamination technology, has announced its financial results for the year ended December 31, 2025. The company reported net sales of $5.6 million, a decrease from $7.7 million in 2024, primarily due to customers deferring capital expenditures amid economic uncertainties. Despite this decline, TOMI highlighted several strategic initiatives aimed at driving long-term growth, including strengthening government relationships and expanding into international markets.

The company achieved a gross profit margin of approximately 55%, reflecting operational efficiency and the value of its Binary Ionization Technology (BIT™). TOMI's service division and recurring BIT™ solution sales were key drivers of revenue, with international sales accounting for 29% of total revenue, up from 21% the previous year.

In terms of operational efficiency, TOMI successfully reduced total operating expenses by about 10% in 2025. The company is also exploring AI technologies to enhance its operations. Looking ahead, TOMI aims to penetrate the food safety market, which is projected to grow significantly, and capitalize on opportunities in the medical device sterilization market.

CEO Dr. Halden Shane expressed optimism about the company's future, emphasizing a strong pipeline of integration projects valued at $16 million and a SteraMist iHP opportunity book of $20 million. TOMI is strategically positioned to leverage global trends in clean manufacturing and biosecurity, focusing on sustainable growth and shareholder value.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.